In contrast to the absence of human CD95L expression in vitro, the analysis of CD95L transcript levels in the tumors of glioma-bearing mice revealed an upregulation of CD95L in vivo in S-24 and ZH-161 xenografts (Fig. 2B, C). This evidence concerns the gene FASLG and glioma.